IRIS
Ingrasciotta, Ylenia
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 2.689
NA - Nord America 2.134
AS - Asia 1.297
SA - Sud America 472
AF - Africa 40
OC - Oceania 2
Totale 6.634
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.078
RU - Federazione Russa 1.522
SG - Singapore 497
BR - Brasile 399
IE - Irlanda 323
CN - Cina 309
SE - Svezia 249
IT - Italia 179
VN - Vietnam 176
HK - Hong Kong 133
DE - Germania 109
PL - Polonia 85
FR - Francia 57
IN - India 41
GB - Regno Unito 38
AR - Argentina 29
CA - Canada 25
BD - Bangladesh 22
FI - Finlandia 22
MX - Messico 18
NL - Olanda 18
IQ - Iraq 15
RO - Romania 15
TR - Turchia 14
UA - Ucraina 13
AT - Austria 12
BE - Belgio 12
JP - Giappone 12
UZ - Uzbekistan 12
EC - Ecuador 11
VE - Venezuela 11
ID - Indonesia 10
MA - Marocco 9
ES - Italia 8
PK - Pakistan 7
ZA - Sudafrica 7
CO - Colombia 6
AZ - Azerbaigian 5
BO - Bolivia 5
EG - Egitto 5
KE - Kenya 5
LT - Lituania 5
CI - Costa d'Avorio 4
JM - Giamaica 4
KZ - Kazakistan 4
PY - Paraguay 4
BY - Bielorussia 3
CH - Svizzera 3
CL - Cile 3
CZ - Repubblica Ceca 3
IR - Iran 3
JO - Giordania 3
KG - Kirghizistan 3
SA - Arabia Saudita 3
TN - Tunisia 3
AE - Emirati Arabi Uniti 2
AL - Albania 2
AO - Angola 2
BH - Bahrain 2
DO - Repubblica Dominicana 2
ET - Etiopia 2
GR - Grecia 2
IL - Israele 2
KW - Kuwait 2
LA - Repubblica Popolare Democratica del Laos 2
LV - Lettonia 2
LY - Libia 2
MY - Malesia 2
NO - Norvegia 2
NP - Nepal 2
PA - Panama 2
PE - Perù 2
TH - Thailandia 2
UY - Uruguay 2
AF - Afghanistan, Repubblica islamica di 1
AM - Armenia 1
BA - Bosnia-Erzegovina 1
BG - Bulgaria 1
BN - Brunei Darussalam 1
CY - Cipro 1
DZ - Algeria 1
GE - Georgia 1
GT - Guatemala 1
HN - Honduras 1
KR - Corea 1
MK - Macedonia 1
NI - Nicaragua 1
NZ - Nuova Zelanda 1
OM - Oman 1
PH - Filippine 1
PR - Porto Rico 1
PS - Palestinian Territory 1
PT - Portogallo 1
QA - Qatar 1
RS - Serbia 1
SV - El Salvador 1
TJ - Tagikistan 1
TV - Tuvalu 1
TW - Taiwan 1
Totale 6.634
Salva come PNG Salva come JPEG
Città #
Ashburn 496
Moscow 441
Chandler 324
Dublin 323
Singapore 253
Dallas 204
Nyköping 140
Hong Kong 133
Dong Ket 106
San Jose 106
Beijing 91
Warsaw 80
Messina 75
Los Angeles 60
The Dalles 53
Princeton 51
Medford 42
Munich 40
São Paulo 38
Lauterbourg 37
New York 35
Ann Arbor 32
Bremen 30
Des Moines 26
Redondo Beach 24
Ho Chi Minh City 23
Frankfurt am Main 21
Tianjin 18
Jacksonville 17
Rome 16
Santa Clara 16
Boardman 15
Focsani 15
Orem 15
Belo Horizonte 14
Rio de Janeiro 14
Brussels 12
Council Bluffs 12
Milan 12
Tashkent 12
Tokyo 12
Buffalo 11
Washington 11
Cambridge 10
Curitiba 10
Dearborn 10
Chennai 9
Guangzhou 9
Hanoi 9
Helsinki 9
Houston 9
Jakarta 9
Montreal 9
Wilmington 9
Campinas 8
Falls Church 8
London 8
Nuremberg 8
Phoenix 8
Pune 8
Amsterdam 7
Brasília 7
Atlanta 6
Baghdad 6
Chicago 6
Haiphong 6
Manchester 6
Mexico City 6
Ningbo 6
Baku 5
Bauru 5
Caltagirone 5
Denver 5
Jinan 5
Juiz de Fora 5
Nairobi 5
Seattle 5
Shenyang 5
Shenzhen 5
Abidjan 4
Brooklyn 4
Campos dos Goytacazes 4
Casablanca 4
Da Nang 4
Ipatinga 4
Johannesburg 4
La Paz 4
Mumbai 4
Nanchang 4
Nanjing 4
Newark 4
Piracicaba 4
Poplar 4
Santa Luzia 4
Shanghai 4
Stockholm 4
Taizhou 4
Toronto 4
Uberlândia 4
Vancouver 4
Totale 3.846
Salva come PNG Salva come JPEG
Nome #
1. Real World Evidence vs. Real World Data: definizioni e razionale 260
Effectiveness and Safety of Switching Originator and Biosimilar Epoetins in Patients with Chronic Kidney Disease in a Large-Scale Italian Cohort Study 231
Association of individual non-steroidal anti-inflammatory drugs and chronic kidney disease: a population-based case control study 224
Comparative Effectiveness of Biosimilar, Reference Product and Other Erythropoiesis-Stimulating Agents (ESAs) Still Covered by Patent in Chronic Kidney Disease and Cancer Patients: An Italian Population-Based Study 186
In search of potential predictors of erythropoiesis-stimulating agents (ESAs) hyporesponsiveness: A population-based study 184
Analgesic drug use in elderly persons: A population-based study in Southern Italy 183
Psoriasis and psoriasiform reactions secondary to Immune Checkpoint Inhibitors 178
Cancer Patients at Risk for Medication-Related Osteonecrosis of the Jaw. A Case and Control Study Analyzing Predictors of MRONJ Onset 171
12. Real World Evidence nelle valutazioni post‑marketing su farmaci generici e biosimilari 168
How Have Intravitreal Anti-VEGF and Dexamethasone Implant Been Used in Italy? A Multiregional, Population-Based Study in the Years 2010–2016 166
Direct healthcare costs of chronic kidney disease management in Italy: What cost-savings can be achieved with higher biosimilar uptake and more appropriate use of erythropoiesis-stimulating agents? 163
Challenges in Post-marketing Studies of Biological Drugs in the Era of Biosimilars: A Report of the International Society for Pharmacoepidemiology 2019 Mid-Year Meeting in Rome, Italy 161
Adverse drug reactions associated with off-label use of ketorolac, with particular focus on elderly patients. An analysis of the Italian pharmacovigilance database and a population based study 157
Real world use of antidiabetic drugs in the years 2011–2017: A population-based study from Southern Italy 157
Large-Scale Postmarketing Surveillance of Biological Drugs for Immune-Mediated Inflammatory Diseases Through an Italian Distributed Multi-Database Healthcare Network: The VALORE Project 147
Are Patients with Psoriasis and Psoriatic Arthritis Undertreated? A Population-Based Study from Southern Italy 145
Comparison of Direct Oral Anticoagulant Use for the Treatment of Non-Valvular Atrial Fibrillation in Pivotal Clinical Trials vs. the Real-World Setting: A Population-Based Study from Southern Italy 145
Biosimilars in Italy: What do real-world data reveal? 145
Kidney disease in diabetic patients: From pathophysiology to pharmacological aspects with a focus on therapeutic inertia 144
Erratum: In search of potential predictors of erythropoiesis-stimulating agents (ESAs) hyporesponsiveness: A population-based study (BMC Nephrology (2019) 20 (359) DOI: 10.1186/s12882-019-1554-0) 141
Efficacy of Systemic Biologic Drugs in Pediatric Psoriasis: Evidence From Five Selected Randomized Clinical Trials 141
Neoplastic implications in patients suffering from hidradenitis suppurativa under systemic treatments 140
Role of healthcare databases and registries for surveillance of orphan drugs in the real-world setting: the Italian case study 139
Chronic Kidney Disease Requiring Healthcare Services: A New Approach to Evaluate Epidemiology of Renal Disease 137
Characteristics and Absolute Survival of Metastatic Colorectal Cancer Patients Treated With Biologics: A Real-World Data Analysis From Three European Countries 137
Novel Therapeutic Approaches to Psoriasis and Risk of Infectious Disease 137
Incidence of Skin Cancer in Patients With Chronic Inflammatory Cutaneous Diseases on Targeted Therapies: A Systematic Review and Meta-Analysis of Observational Studies 133
Testing of Coding Algorithms for Inflammatory Bowel Disease Identification, as Indication for Use of Biological Drugs, Using a Claims Database from Southern Italy 132
Antidepressants and the Risk of Cardiovascular Events in Elderly Affected by Cardiovascular Disease: A Real-Life Investigation From Italy 130
In Search of Predictors of Switching Between Erythropoiesis-Stimulating Agents in Clinical Practice: A Multi-Regional Cohort Study 125
The economic burden of preventable adverse drug reactions: a systematic review of observational studies 119
Pattern of Use of Biosimilar and Originator Somatropin in Italy: A Population-Based Multiple Databases Study During the Years 2009-2014 117
Pharmacokinetics of new oral anticoagulants: implications for use in routine care 115
Medication is an additional source of phosphate intake in chronic kidney disease patients 111
Safety of Biologics, Including Biosimilars: Perspectives on Current Status and Future Direction. 109
How did the Introduction of Biosimilar Filgrastim Influence the Prescribing Pattern of Granulocyte Colony-Stimulating Factors? Results from a Multicentre, Population-Based Study, from Five Italian Centres in the Years 2009–2014 105
The Burden of Nephrotoxic Drug Prescriptions in Patients with Chronic Kidney Disease: A Retrospective Population-Based Study in Southern Italy 100
The Role of European Healthcare Databases for Post-Marketing Drug Effectiveness, Safety and Value Evaluation: Where Does Italy Stand? 98
Hidradenitis suppurativa and psoriasis: the odd couple 97
Hidradenitis Suppurativa in Patients with HIV: A Scoping Review 95
Epidemiological analysis to identify predictors of X-linked hypophosphatemia (XLH) diagnosis in an Italian pediatric population: the EPIX project 92
Vitiligo-like Lesions and COVID-19: Case Report and Review of Vaccination- and Infection-Associated Vitiligo 92
Interchangeability of biosimilar and biological reference product: updated regulatory positions and pre- and post-marketing evidence. 89
The advent of biosimilars for the treatment of diabetes: current status and future directions 86
How Much Are Biosimilars Used in Clinical Practice? A Retrospective Italian Population-Based Study of Erythropoiesis-Stimulating Agents in the Years 2009-2013 85
Quanto sono utilizzati in Italia i farmaci biosimilari? Uno studio retrospettivo sull'uso degli agenti stimolanti l'eritropoiesi negli anni 2009-2013 83
Recent advances in the management of chemotherapy-induced neutropenia: Biosimilar granulocyte colony-stimulating factor use in Italy 83
Non-Motherhood between Obligation and Choice: Statistical Analysis Based on Permutation Tests of Spontaneous and Induced Abortion Rates in the Italian Context 80
Safety and potential interaction of immunosuppressive drugs for the treatment of inflammatory bowel disease in elderly patients 70
null 37
null 28
null 24
null 19
null 18
null 17
Totale 6.776
Salva come PNG Salva come JPEG
Categoria #
all - tutte 24.546
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 24.546
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021107 0 0 0 0 0 0 0 0 0 0 0 107
2021/2022380 2 23 2 4 16 8 46 5 24 83 33 134
2022/2023945 71 107 37 89 79 94 14 37 378 5 24 10
2023/2024292 17 30 27 31 30 93 15 5 3 14 1 26
2024/20251.110 26 14 19 63 56 44 45 217 264 96 104 162
2025/20263.483 214 219 258 220 323 717 369 488 443 159 56 17
Totale 6.776